Zepp Health Corporation Sponsored ADR

ZEPP Technology Consumer Electronics

Zepp Health Corporation Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $258.9 million, up 41.8% from fiscal 2024.

Revenue
+6.93%
EPS
−46.9%
Free cash flow
−103.7%
Total debt
+26.4%

Quarter to June 2026, against a year earlier

2.34 0.12 +5.41%
Market cap
$18.8M
P/E
0.0×
Fwd P/E
−22.0×
Dividend yield
—
F-score
5/9
Altman Z
1.01
Beneish M
−2.49
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

— 5 — —
ROE
(24.35%) (17.15%) (18.76%) (21.23%)
ROA
(11.23%) (7.33%) (7.60%) (7.86%)
ROIC
(9.25%) (8.43%) (8.18%) (10.25%)
Return on Tangible Assets
(208.31%) (324.62%) 135.69% 164.91%
Average Days of Receivables
136.43 103.73 83.77 109.21
Free Cash Flow per Share
0.00 (0.74) 0.00 0.00
Free Cash Flow
— (11.76) — —
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026